Tilman U. Esser

Tilman U. Esser

Auto-generated profile, based on publicly available information

Tilman U. Esser

Experimental Renal and Cardiovascular Research Department of Nephropathology Institute of Pathology Friedrich‐Alexander‐Universität Erlangen‐Nürnberg (FAU) Muscle Research Center Erlangen (MURCE) 91054 Erlangen Germany

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2023 in Advanced Materials
Verified
Journal Article
Open access
TETilman U. Esser
Tilman U. Esser
AAAnnalise Anspach
Annalise Anspach
KMKatrin A. Muenzebrock
Katrin A. Muenzebrock
DKDelf Kah
Delf Kah
SSStefan Schrüfer
Stefan Schrüfer
Felix EngelFelix Engel
Felix Engel
3D‐bioprinting is a promising technology to produce human tissues as drug screening tool or for organ repair. However, direct printing of living cells has proven difficult. Here, a method is presented to directly 3D‐bioprint human induced pluripotent stem cell (hiPSC)‐derived cardiomyocytes embedded in a collagen–hyaluronic acid ink, generating centimeter‐sized functional ring‐ and ventricle‐shaped cardiac tissues in an accurate and reproducible manner. The printed tissues contain hiPSC‐derived cardiomyocytes with well‐organized sarcomeres and exhibit spontaneous and regular contractions, which persist for several months and are able to contract against passive resistance. Importantly, beating frequencies of the printed cardiac tissues can be modulated by pharmacological stimulation. This approach opens up new possibilities for generating complex functional cardiac tissues as models for advanced drug screening or as tissue grafts for organ repair or replacement.

26 July 2021 in ChemMedChem
Verified
Journal Article
Open access
PDF file
FRFarah S. Raad
Farah S. Raad
TKTaukeer Ahmad Khan
Taukeer Ahmad Khan
TETilman U. Esser
Tilman U. Esser
JHJames E. Hudson
James E. Hudson
BSBhakti Irene Seth
Bhakti Irene Seth
WZWolfram-Hubertus Zimmermann
Wolfram-Hubertus Zimmermann
Human pluripotent stem cells (hPSCs) hold great promise for applications in cell therapy and drug screening in the cardiovascular field. Bone morphogenetic protein 4 (BMP4) is key for early cardiac mesoderm induction in hPSC and subsequent cardiomyocyte derivation. Small‐molecular BMP4 mimetics may help to standardize cardiomyocyte derivation from hPSCs. Based on observations that chalcones can stimulate BMP4 signaling pathways, we hypothesized their utility in cardiac mesoderm induction. To test this, we set up a two‐tiered screening strategy, (1) for directed differentiation of hPSCs with commercially available chalcones (4’‐hydroxychalcone [4’HC] and Isoliquiritigen) and 24 newly synthesized chalcone derivatives, and (2) a functional screen to assess the propensity of the obtained cardiomyocytes to self‐organize into contractile engineered human myocardium (EHM). We identified 4’HC, 4‐fluoro‐4’‐methoxychalcone, and 4‐fluoro‐4’‐hydroxychalcone as similarly effective in cardiac mesoderm induction, but only 4’HC as an effective replacement for BMP4 in the derivation of contractile EHM‐forming cardiomyocytes.

12 June 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
TETilman U. Esser
Tilman U. Esser
AAAnnalise Anspach
Annalise Anspach
KMKatrin A. Muenzebrock
Katrin A. Muenzebrock
DKDelf Kah
Delf Kah
SSStefan Schruefer
Stefan Schruefer
Felix EngelFelix Engel
Felix Engel
3D-bioprinting is a promising technology to produce human tissues as drug screening tool or for organ repair. However, direct printing of living cells has proven difficult. Here, we present a method to directly 3D-bioprint human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes embedded in a collagen-hyaluronic acid ink generating centimeter-sized functional ring- and ventricle-shaped cardiac tissues in an accurate and reproducible manner. The printed tissues contained hiPSC-derived cardiomyocytes with well-organized sarcomeres and exhibited spontaneous and regular contractions, which persisted for several months and were able to contract against passive resistance. Importantly, beating frequencies of the printed cardiac tissues could be modulated by pharmacological stimulation. This approach opens up new possibilities for generating complex functional cardiac tissues as models for advanced drug screening or as tissue grafts for organ repair or replacement.